Regency Capital Management’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.17M | Sell |
665,881
-83,601
| -11% | -$523K | 2.19% | 18 |
|
|
2025
Q1 | $4.39M | Buy |
749,482
+140,058
| +23% | +$821K | 2.62% | 14 |
|
|
2024
Q4 | $5.01M | Sell |
609,424
-57,887
| -9% | -$476K | 2.71% | 15 |
|
|
2024
Q3 | $5.95M | Sell |
667,311
-97,744
| -13% | -$871K | 3.27% | 13 |
|
|
2024
Q2 | $5.78M | Sell |
765,055
-20,081
| -3% | -$152K | 3.72% | 10 |
|
|
2024
Q1 | $6.16M | Buy |
785,136
+80,162
| +11% | +$629K | 3.92% | 10 |
|
|
2023
Q4 | $6.25M | Buy |
704,974
+177,996
| +34% | +$1.58M | 4.2% | 7 |
|
|
2023
Q3 | $4.73M | Sell |
526,978
-5,355
| -1% | -$48K | 4.02% | 9 |
|
|
2023
Q2 | $6.57M | Sell |
532,333
-11,342
| -2% | -$140K | 5.72% | 6 |
|
|
2023
Q1 | $5.05M | Sell |
543,675
-10,611
| -2% | -$98.5K | 6.11% | 5 |
|
|
2022
Q4 | $5.82M | Buy |
554,286
+329,732
| +147% | +$3.46M | 6.69% | 5 |
|
|
2022
Q3 | $4.07M | Sell |
224,554
-30,068
| -12% | -$545K | 4.99% | 6 |
|
|
2022
Q2 | $3.61M | Buy |
+254,622
| New | +$3.61M | 3.88% | 12 |
|